share_log

ThinkEquity Initiates Coverage On Vivani Medical With Buy Rating, Announces Price Target of $7

ThinkEquity Initiates Coverage On Vivani Medical With Buy Rating, Announces Price Target of $7

ThinkEquity以买入评级启动对Vivani Medical的保险,宣布目标股价为7美元
Benzinga Real-time News ·  2022/12/05 09:18

ThinkEquity analyst Ashok Kumar initiates coverage on Vivani Medical (NASDAQ:VANI) with a Buy rating and announces Price Target of $7.

ThinkEquity分析师阿肖克·库马尔以买入评级启动了对Vivani Medical(纳斯达克股票代码:VANI)的报道,并宣布目标股价为7美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发